{"organizations": [], "uuid": "d21c0112fca7e2949b40c67c59b039078df3f5a8", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180329.html", "section_title": "Archive News &amp; Video for Thursday, 29 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-insmed-inc-submits-nda-to-fda-for/brief-insmed-inc-submits-nda-to-fda-for-alis-idUSASC09U6T", "country": "US", "domain_rank": 408, "title": "Insmed Inc Submits NDA To FDA For ALIS", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.455, "site_type": "news", "published": "2018-03-29T20:26:00.000+03:00", "replies_count": 0, "uuid": "d21c0112fca7e2949b40c67c59b039078df3f5a8"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-insmed-inc-submits-nda-to-fda-for/brief-insmed-inc-submits-nda-to-fda-for-alis-idUSASC09U6T", "ord_in_thread": 0, "title": "Insmed Inc Submits NDA To FDA For ALIS", "locations": [], "entities": {"persons": [], "locations": [{"name": "insmed", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "insmed inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "mac", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 29 (Reuters) - Insmed Inc:\n* INSMED SUBMITS NEW DRUG APPLICATION TO FDA FOR ALIS IN NTM LUNG DISEASE CAUSED BY MAC\n* INSMED - ANTICIPATES RECEIVING A SIX-MONTH PRIORITY REVIEW AND THAT NDA WILL BE REVIEWED BY DIVISION OF ANTI-INFECTIVE PRODUCTS Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-03-29T20:26:00.000+03:00", "crawled": "2018-03-30T12:45:37.008+03:00", "highlightTitle": ""}